<DOC>
	<DOCNO>NCT01110642</DOCNO>
	<brief_summary>This open label-pilot study assess efficacy safety novel cholesterol-lovastatin topical solution child rare syndromic ichthyoses . Often time , child difficulty find easily apply treatment make psoriasiform ichthyotic plaque manageable . We propose use cholesterol-lovastatin topical solution treatment option hypothesis lead regression involve area decrease erythema warty-like appearance plaque . We plan enroll child syndromic ichthyoses age 1 year 12 month study total 5 visit 5 phone call .</brief_summary>
	<brief_title>Novel Treatment Syndromic Ichthyoses</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ichthyosis</mesh_term>
	<mesh_term>Ichthyosis , Lamellar</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>Informed Consent form sign subject subject 's legal representative ; also , subject age majority capable provide assent , sign assent subject . Diagnosis syndromic ichthyoses ( verified Dr Amy S. Paller ) . Children adults 12 month age Use investigational drug within 30 day enrollment . Current malignancy . Pregnancy breastfeed study . ( All female subject childbearing potential assessed pregnancy visit . )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>